PDS Biotechnology Corporation
USD1.16
+0.02 (+1.75%)
CEO
Frank K. Bedu-Addo
IPO Date
2015-09-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.15
Prev. Close
$1.14
Day Low
$1.12
Day High
$1.23
52W Low
$0.51
52W High
$1.92
Market Cap
$0.06B
Volume
1.08M
| 150,000 |
| $0.98 |
| 3 Mar 2026 | Shepard Kirk V. | Chief Medical Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Boesgaard Lars | Chief Financial Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Brown Spencer D. | Senior VP, General Counsel | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Toutain Stephan | Chief Operating Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Freitag Gregory Gene | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | Iliev Ilian | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | Ali-Jackson Kamil | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | BRAWLEY OTIS W | director | A-Award | Acquired | 54,876 | $0.98 |